Innate immunity and remodelling

Heart Failure Reviews

Volumn 16, Issue 1, 2011, Pages 71-78

  Valen, Guro ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Cytokines; Heart failure; Nuclear factor kappa B; Toll like receptors

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CARDIAC REMODELING; CARDIOVASCULAR FUNCTION; CD4+ CD25+ T LYMPHOCYTE; DENDRITIC CELL; EXTRACELLULAR MATRIX; GENE ACTIVATION; GENE EXPRESSION REGULATION; HEART FAILURE; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; ISCHEMIC PRECONDITIONING; MACROPHAGE; MOLECULAR DYNAMICS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UBIQUITINATION;

EID: 78650976225     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10741-010-9187-1     Document Type: Article

References (74)

1. M-W Chung T Tsoutsman C Semsarian 2003 Hypertrophic cardiomyopathy: from gene to defect to clinical disease Cell Res 13 9 20 1:CAS:528: DC%2BD2cXivVSit74%3D 10.1038/sj.cr.7290146 12643345 (Pubitemid 43231857)
2. GS Francis WH Tang 2003 Pathophysiology of congestive heart failure Rev Cardiovasc Med 4 S14 S20 12776009
3. A Yndestad JK Damås E Øie T Ueland L Gullestad P Aukrust 2007 Role of inflammation in the progression of heart failure Curr Cardiol Rep 9 236 241 10.1007/BF02938356 17470337
4. MU Sani 2008 Myocardial disease in human immunodeficiency virus (HIV) infection: a review Wien Klin Wochenschr 120 77 87 10.1007/s00508-008-0935-3 18322768 (Pubitemid 351361645)
5. A Sandek M Rauchhaus SD Anker S von Haehling 2008 The emerging role of the gut in chronic heart failure Curr Opin Clin Nutr Metab Care 11 632 639 10.1097/MCO.0b013e32830a4c6e 18685461
6. SS Dhawan AA Quyyumi 2008 Rheumatoid arthritis and cardiovascular disease Curr Atheroscl Rep 10 128 133 1:CAS:528:DC%2BD1cXkslykurs%3D 10.1007/s11883-008-0019-x (Pubitemid 351486147)
7. RS Whelan V Kaplinskiy RN Kitsis 2010 Cell death in the pathogenesis of heart disease: mechanisms and significance Annu Rev Physiol 72 19 44 1:CAS:528:DC%2BC3cXktFKktr0%3D 10.1146/annurev.physiol.010908.163111 20148665
8. L Zelarayan A Renger C Noack MP Zafiriou C Gehrke R van der Nagel R Dietz L de Windt MW Bergmann 2009 NFκB activation is required for adaptive cardiac hypertrophy Cardiovasc Res 84 416 424 1:CAS:528:DC%2BD1MXhsVGnurfE 10.1093/cvr/cvp237 19620128
9. N Hedhi C Depre 2010 Proteasome inhibitors and cardiac cell growth Cardiovasc Res 85 321 329 10.1093/cvr/cvp226
10. VM Conraads CJ Vrints IE Rodrigus VY Hoymans EM Van Craenenbroeck J Bosmans MJ Claeys P Van Herch A Linke G Schuler V Adams 2010 Depressed expression of MuRF1 and MAFbx in areas of recent myocardial infarction: a mechanism contributing to myocardial remodelling? Basis Res Cardiol 105 219 226 1:CAS:528:DC%2BC3cXnvFWktQ%3D%3D 10.1007/s00395-009-0068-5
11. ÅB Gustafsson RA Gottlieb 2009 Autophagy in ischemic heart disease Circ Res 104 150 158 1:CAS:528:DC%2BD1MXntFahsA%3D%3D 10.1161/CIRCRESAHA.108. 187427 19179668
12. JE Fildes SM Shaw N Yonan SG Williams 2009 The immune system and chronic heart failure. Is the heart in control? J Am Coll Cardiol 53 1013 1020 1:CAS:528:DC%2BD1MXjsVKrtbw%3D 10.1016/j.jacc.2008.11.046 19298913
13. Gottlieb RA, Carreira RS (2010) Autophagy in health and disease: V. mitophagy as a way of life. Am J Physiol (epub ahead of print)
14. S Akira K Takeda 2004 Toll-like receptor signaling Nat Rev Immunol 4 499 511 1:CAS:528:DC%2BD2cXlt1Cqur0%3D 10.1038/nri1391 15229469
15. NW Palm R Medzhitov 2009 Pattern recognition receptors and control of adaptive immunity Immunol Rev 227 221 233 1:CAS:528:DC%2BD1MXhsFGls73I 10.1111/j.1600-065X.2008.00731.x 19120487
16. ZQ Yan GK Hansson 2007 Innate immunity, macrophage activation, and atherosclerosis Immunol Rev 219 187 203 1:CAS:528:DC%2BD2sXht1Cnt7zE 10.1111/j.1600-065X.2007.00554.x 17850490 (Pubitemid 47390007)
17. O Takeuchi S Akira 2010 Pattern recognition receptors and inflammation Cell 140 805 820 1:CAS:528:DC%2BC3cXlsVSgu74%3D 10.1016/j.cell.2010.01.022 20303872
18. P Matzinger 2002 The danger model: a renewed sense of self Science 296 301 305 1:CAS:528:DC%2BD38XjtVWiurk%3D 10.1126/science.1071059 11951032 (Pubitemid 34303674)
19. P Matzinger 2007 Friendly and dangerous signals: is the tissue in control? Nat Immunol 8 11 13 1:CAS:528:DC%2BD28Xhtlaqs7bF 10.1038/ni0107-11 17179963 (Pubitemid 46242350)
20. B Erickson K Sperber WH Frishman 2008 Toll-like receptors. New therapy strategies for the treatment of atherosclerosis, acute coronary syndroms, and myocardial failure Cardiol Rev 16 237 279 10.1097/CRD.0b013e3181709fd8
21. Y Shi JE Evans KL Rode 2003 Molecular identification of a danger signal that alerts the immune system to dying cells Nature 425 516 521 1:CAS:528:DC%2BD3sXnslSis7g%3D 10.1038/nature01991 14520412 (Pubitemid 37237047)
22. S Frantz G Ertl J Bauersachs 2007 Mechanisms of disease: toll-like receptors in cardiovascular disease Nat Clin Pract Cardiovasc Med 4 444 454 1:CAS:528:DC%2BD2sXotVOiu78%3D 10.1038/ncpcardio0938 17653117 (Pubitemid 47180328)
23. MS Hayden AP West S Ghosh 2006 NF-kappaB and the immune response Oncogene 25 6758 6780 1:CAS:528:DC%2BD28XhtFektL7P 10.1038/sj.onc.1209943 17072327 (Pubitemid 44657851)
24. HS Valeur G Valen 2009 Innate immunity and myocardial adaptation to ischemia Basic Res Cardiol 104 22 32 1:CAS:528:DC%2BD1MXksVartA%3D%3D 10.1007/s00395-008-0756-6 18931966
25. H Tang Y Zhong Y Zhu F Zhao X Cui Z Wang 2010 Low responder T cell susceptibility to the suppressive function of regulatory T cells in patients with dilated cardiomyopathy Heart 96 765 772 1:CAS:528:DC%2BC3cXnvVagsrg%3D 10.1136/hrt.2009.184945 20448127
26. low regulatory T cells in patients with chronic heart failure Cellular Physiol Biochem 25 451 458 1:CAS:528:DC%2BC3cXjslSksLc%3D 10.1159/000303050
27. H Kvakan M Kleinewietfeld F Qadri JK Park R Fischer I Schwarz HP Rahn R Plehm M Wellner S Elitok P Gratze R Dechend FC Luft DN Muller 2009 Regulatory T cells ameliorate angiotensin II induced cardiac damage Circulation 119 2904 2912 1:CAS:528:DC%2BD1MXms1alsb8%3D 10.1161/CIRCULATIONAHA.108.832782 19470887
28. HRS Girn S Ahilathirunayagam AID Mavor S Homer-Vanniasinkam 2007 Reperfusion syndrome: cellular mechanisms of microvascular dysfunction and potential therapeutic strategies Vasc Endovasc Surg 41 277 293 10.1177/1538574407304510 (Pubitemid 47258443)
29. M Kurdi GW Booz 2007 Can the protective actions of JAK-STAT in the heart be exploited therapeutically? Parsing the regulation of interleukin-6-type cytokine signalling J Cardiovasc Pharmacol 50 126 141 1:CAS:528: DC%2BD2sXptFemsbo%3D 10.1097/FJC.0b013e318068dd49 17703129 (Pubitemid 47267738)
30. E Chorianopoulos T Heger M Lutz D Frank F Bea HA Katus N Frey 2010 FGF-inducible 14-kDA protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor kappa B activation by TWEAK Basic Res Cardiol 105 301 313 1:CAS:528:DC%2BC3cXnvFWrsg%3D%3D 10.1007/s00395-009-0046-y 19629561
31. T Lawrence C Fong 2010 The resolution of inflammation: anti-inflammatory roles for NF-kB Int J Biochem Cell Biol 42 519 523 1:CAS:528: DC%2BC3cXivFKitLY%3D 10.1016/j.biocel.2009.12.016 20026420
32. G Hall JD Hasday TB Rogers 2006 Regulating the regulator: NF-kappaB signaling in the heart J Mol Cell Cardiol 41 580 591 1:CAS:528: DC%2BD28Xps1Oks7Y%3D 10.1016/j.yjmcc.2006.07.006 16949095 (Pubitemid 44374539)
33. WK Jones M Brown M Wilhide S He X Ren 2005 NF-kappaB in cardiovascular disease: diverse and specific effects of a "general" transcription factor? Cardiovasc Toxicol 5 183 202 1:CAS:528:DC%2BD2MXhtVagsr3L 10.1385/CT:5:2:183 16046793 (Pubitemid 41058631)
34. G Valen ZQ Yan GK Hansson 2001 Nuclear factor kappa-B and the heart J Am Coll Cardiol 38 307 314 1:CAS:528:DC%2BD3MXmtF2qt7o%3D 10.1016/S0735-1097(01) 01377-8 11499717 (Pubitemid 32721754)
35. G Valen 2004 Signal transduction through nuclear factor kappa B in ischemia-reperfusion and heart failure Basic Res Cardiol 99 1 7 1:CAS:528:DC%2BD2cXhtFKisbw%3D 10.1007/s00395-003-0442-7 14685699 (Pubitemid 38049133)
36. B Chandrasekar GL Freeman 1997 Induction of nuclear factor kappaB and activation protein 1 in postischemic myocardium FEBS Lett 401 30 34 1:CAS:528:DyaK2sXns1Shug%3D%3D 10.1016/S0014-5793(96)01426-3 9003800 (Pubitemid 27051252)
37. C Li W Browder RL Kao 1999 Early activation of transcription factor NF-kappaB during ischemia in perfused rat heart Am J Physiol 276 H543 H552 1:CAS:528:DyaK1MXhtlCktrY%3D 9950856
38. C Li RL Kao T Ha J Kelley IW Browder DL Williams 2001 Early activation of IKKbeta during in vivo myocardial ischemia Am J Physiol 280 H1264 H1271 1:CAS:528:DC%2BD3MXjtV2nsrk%3D
39. G Valen GK Hansson A Dumitrescu J Vaage 2000 Unstable angina activates myocardial heat shock protein 72, endothelial nitric oxide synthase, and transcription factors NFkB and AP-1 Cardiovasc Res 47 49 56 1:CAS:528: DC%2BD3cXktlCrsL4%3D 10.1016/S0008-6363(00)00071-7 10869529 (Pubitemid 30408549)
40. ME Ritchie 1998 Nuclear factor-κB is selectively and markedly activated in humans with unstable angina pectoris Circulation 98 1707 1713 1:CAS:528:DyaK1cXnt1KlsrY%3D 9788823
41. R Morishita T Sugimoto M Aoki I Kida N Tomita A Moriguchi K Maeda Y Sawa Y Kaneda J Higaki T Ogihara 1997 In vivo transfection of cis element "decoy" against nuclear factor-kB binding site prevents myocardial infarction Nat Med 3 8 894 899 1:CAS:528:DyaK2sXltVOhs7g%3D 10.1038/nm0897-894 9256281 (Pubitemid 27353450)
42. Y Sawa R Morishita K Suzuki K Kagisaki Y Kaneda K Maeda K Kadoba H Matsuda 1997 A novel strategy for myocardial protection using in vivo transfection of cis element "decoy" against NFkB binding site Circulation 96 suppl. II II-280 II-285
43. EN Morgan EM Boyle W Yun JM Griscavage-Ennis A Farr TG Canty TH Pohlman ED Verrier 1999 An essential role for NFkB in the cardioadaptive response to ischemia Ann Thorac Surg 68 377 382 1:STN:280:DyaK1Mvgt1ertw%3D%3D 10.1016/S0003-4975(99)00646-3 10475400 (Pubitemid 29521080)
44. SCY Wong M Fukuchi P Melnyk I Rodger A Giaid 1998 Induction of cyclooxygenase-2 and activation of nuclear factor κB in myocardium of patients with congestive heart failure Circulation 98 100 103 1:CAS:528:DyaK1cXkvVSqu7s%3D 9679714
45. S Frantz D Fracarollo H Wagner TM Behr P Jung CE Angermann G Ertl J Bausersachs 2003 Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure Cardiovasc Res 57 749 756 1:CAS:528:DC%2BD3sXhs1ehtrw%3D 10.1016/S0008-6363(02)00723-X 12618236 (Pubitemid 36254868)
46. S Gupta S Sen 2005 Role of the NFκB signalling cascade and NFκB targeted genes in failing human hearts J Mol Med 83 993 1004 1:CAS:528:DC%2BD2MXht1OksrfP 10.1007/s00109-005-0691-z 16133425 (Pubitemid 41745758)
47. S Frantz S Stoerk H Wagner CE Angermann G Ertl J Bauersachs 2004 Effect of chronic heart failure on nuclear factor kappa B in peripheral leukocytes Am J Cardiol 94 671 673 1:CAS:528:DC%2BD2cXntlenu7s%3D 10.1016/j.amjcard.2004.05.041 15342308 (Pubitemid 39165855)
48. J Siednienko EA Jankowska W Banasiak WA Gorczyca P Ponikowski 2007 Nuclear factor kappa B activity in peripheral blood mononuclear cells in cachectic and non-cachectic patients with chronic heart failure Int J Cardiol 122 111 116 10.1016/j.ijcard.2006.03.095 17270295 (Pubitemid 47552583)
49. V Adams U Säte N Kränkel PC Schulze A Linke G Schuler R Hambrecht 2003 Nuclear factor kappa B activation in skeletal muscle of patients with chronic heart failure: correlation with the expression of inducible nitric oxide synthase Eur J Cardiovasc Prev Rehabil 10 273 277 10.1097/00149831- 200308000-00009 14555882 (Pubitemid 37433492)
50. L Timmers K van Keulen IE Hoefer MFL Meijs B van Middelaar K den Ouden CJA van Echteld G Pasterkamp DPV de Kleijn 2009 Targeted deletion of nuclear factor κB p50 enhances cardiac remodelling and dysfunction following myocardial infarction Circ Res 104 699 706 1:CAS:528:DC%2BD1MXisFelur0%3D 10.1161/CIRCRESAHA.108.189746 19168865
51. S Frantz K Hu B Bayer S Gerondakis J Strotmann A Adamek G Ertl J Bauersachs 2006 Absence of NFκB subunit p50 improves heart failure after myocardial infarction FASEB J 20 1918 1920 1:CAS:528:DC%2BD28XptlGqtrk%3D 10.1096/fj.05-5133fje 16837548 (Pubitemid 44933779)
52. S Kawano T Kubota Y Monden T Tsutsumi T Inoue N Kawamura H Tsutsui K Sunagawa 2006 Blockade of NFκB improves cardiac function and survival after myocardial infarction Am J Physiol 291 H1337 H1344 1:CAS:528: DC%2BD28XhtVSksrbO
53. N Kawamura T Kubota S Kawano Y Monden AM Feldman H Tsutsui A Takeshita K Sunagawa 2005 Blockade of NFκB improves cardiac function and survival without affecting inflammation in TNFα-induced cardiomyopathy Cardiovasc Res 66 520 529 1:CAS:528:DC%2BD2MXks1anurY%3D 10.1016/j.cardiores.2005.02.007 15914117 (Pubitemid 40725764)
54. S Gupta D Young RK Maitra A Gupta ZB Popovic SL Yong A Mahajan Q Wang S Sen 2008 Prevention of cardiac hypertrophy and heart failure by silencing of NFκB J Mol Biol 375 637 649 1:CAS:528:DC%2BD2sXhsVOlt73F 10.1016/j.jmb.2007.10.006 18037434
55. D Young ZB Popovic WK Jones S Gupta 2008 Blockade of NFκB using IκBα dominant negative mice ameliorates cardiac hypertrophy in myotrophin overexpressed transgenic mice J Mol Biol 381 559 568 1:CAS:528:DC%2BD1cXpt1KisLs%3D 10.1016/j.jmb.2008.05.076 18620706
56. S Wakatsuki J-I Suzuki M Ogawa M Masumura S Muto T Shimizu K Takayama A Itai M Isobe 2008 A novel IKK inhibitor suppresses heart failure and chronic remodelling after myocardial ischemia via MMP alteration Expert Opin Ther Targets 12 1469 1476 1:CAS:528:DC%2BD1cXhtlKrtL7I 10.1517/14728220802551140 19007316
57. S Hikoso O Yamaguchi Y Nakano T Takeda S Omiya I Mizote M Taneike T Oka T Tamai J Oyabu Y Uno Y Matsumura K Nishida K Suzuki M Kogo M Hori K Otsu 2009 The IκB kinase β/nuclear factor κB signaling pathway protects the heart from hemodynamic stress mediated by the regulation of manganese superoxide dismutase expression Circ Res 105 70 79 1:CAS:528: DC%2BD1MXns1Chtrw%3D 10.1161/CIRCRESAHA.108.193318 19478205
58. P Kratsios M Huth L Temmerman E Salimova M Al Banchaabouchi A Sgoifo M Manghi K Suzuki N Rosenthal F Mourkioti 2010 Antioxidant amelioration of dilated cardiomyopathy caused by conditional deletion of NEMO/IKKγ in cardiomyocytes Circ Res 106 133 144 1:CAS:528:DC%2BD1MXhs1aqt7nK 10.1161/CIRCRESAHA.109.202200 19850942
59. M Satoh Y Shimoda C Maesawa T Akatsu Y Ishikawa Y Minami K Hiramori M Nakamura 2006 Activated toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarction Int J Cardiol 109 226 234 10.1016/j.ijcard.2005.06.023 16051384
60. S Frantz RA Kelly T Bourcier 2001 Role of TLR-2 in the activation of nuclear factor kappaB by oxidative stress in cardiac myocytes J Biol Chem 276 5197 5203 1:CAS:528:DC%2BD3MXhtlyjs78%3D 10.1074/jbc.M009160200 11083876
61. S Frantz L Kobzik YD Kim R Fukazawa R Medzhitov RT Lee RA Kelly 1999 Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium J Clin Invest 104 271 280 1:CAS:528:DyaK1MXkvFagtr4%3D 10.1172/JCI6709 10430608
62. JM Brown MA Grosso LS Terada GJ Whitman A Banerjee CW White AH Harken JE Repine 1989 Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat hearts Proc Natl Acad Sci 86 2516 2520 1:CAS:528:DyaL1MXitVOmtrk%3D 10.1073/pnas.86.7.2516 2648406 (Pubitemid 19102539)
63. AJ Chong A Shimamoto CR Hampton H Takayama DJ Spring CL Rothnie M Yada TH Pohlman ED Verrier 2004 Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart J Thorac Cardiovasc Surg 128 170 179 1:CAS:528: DC%2BD2cXntVGqurc%3D 10.1016/j.jtcvs.2004.03.049 15282452 (Pubitemid 39388937)
64. W Song BL Furman JR Parratt 1998 Monophosphoryl lipid A reduces both arrhythmia severity and infarct size in a rat model of ischaemia Eur J Pharmacol 345 285 287 1:CAS:528:DyaK1cXitVKisb0%3D 10.1016/S0014-2999(98)00126-5 9592028 (Pubitemid 28179570)
65. S Belosjorow R Schulz H Dörge FU Schade G Heusch 1999 Endotoxin and ischemic preconditioning: TNF-α concentration and myocardial infarct size development in rabbits Am J Physiol 277 H2470 H2475 1:CAS:528:DC%2BD3cXps1al 10600870
66. S Nemeto JG Vallejo P Knuefermann A Misra G Defreitas BA Carabello DL Mann 2002 Escherichia coli LPS-induced LV dysfunction: role of toll-like receptor 4 in the adult heart Am J Physiol 282 H2323 H2361
67. J Favre P Musette V Douin-Echinard K Laude JP Henry JF Arnal C Thuillez V Richard 2007 Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction Arterioscler Thromb Vasc Biol 27 1064 1071 1:CAS:528:DC%2BD2sXktFagtbk%3D 10.1161/ATVBAHA.107.140723 17332486 (Pubitemid 46641958)
68. N Nozaki T Shishido Y Takeishi I Kubota 2004 Modulation of doxorubin-induced cardiac dysfunction in toll-like receptor-2-knockout mice Circulation 110 2869 2874 1:CAS:528:DC%2BD2cXptVejs74%3D 10.1161/01.CIR. 0000146889.46519.27 15505089 (Pubitemid 39473611)
69. J Oyama C Blais X Liu M Pu L Kobzik RA Kelley T Bourcier 2004 Reduced myocardial ischemia-reperfusion injury in Toll-like receptor 4-deficient mice Circulation 109 784 789 1:CAS:528:DC%2BD2cXhtFWltbw%3D 10.1161/01.CIR. 0000112575.66565.84 14970116 (Pubitemid 38222900)
70. SC Kim A Ghanem H Stapel 2007 Toll-like receptor 4 deficiency: smaller infarcts, but no gain in function BMC Physiol 7 5 9 10.1186/1472-6793-7-5 17592640 (Pubitemid 47206831)
71. T Ha F Liu J Ma X Gao J Kelley A Zhao GE Haddad DL Williams I William Browder RL Kao C Li 2005 Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload Cardiovasc Res 68 224 234 1:CAS:528:DC%2BD2MXhtFWntLvI 10.1016/j.cardiores.2005.05.025 15967420 (Pubitemid 41428419)
72. L Timmers JP Sluijter JK van Keulen IE Hoefer MG Nederhof MJ Goumans PA Doevendans CJ van Echteld JA Joles PH Quax JJ Piek G Pasterkamp DP de Kleijn 2008 Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction Circ Res 102 257 264 1:CAS:528:DC%2BD1cXhtVGkur8%3D 10.1161/CIRCRESAHA.107.158220 18007026 (Pubitemid 351674064)
73. YY Liu WF Cai HZ Yang B Ciu ZR Chen HZ Liu J Yan W Jin HM Yan BM Xin B Yuan F Hua ZW Hu 2008 Bacillus Calmette-Guerin and TLR4 agonist prevent cardiovascular hypertrophy and fibrosis by regulating immune microenvironment J Immunol 180 7349 7357 1:CAS:528:DC%2BD1cXmtVanuro%3D 18490734
74. T Shishido N Nozaki S Yamaguchi Y Shibata J Nitobe T Miyamoto H Takahashi T Arimoto K Maeda M Yamakawa O Takeuchi S Akira Y Takeishi I Kubota 2003 Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction Circulation 108 2905 2910 1:CAS:528:DC%2BD3sXptlyjtr8%3D 10.1161/01.CIR.0000101921.93016.1C 14656915 (Pubitemid 37517819)